venBio is a venture capital firm focused on life sciences, partnering with industry leaders to advance novel therapeutics and biotech technologies. The firm supports companies across the drug development spectrum, including research, chemistry, manufacturing, clinical trial design, and regulatory strategy, with the aim of bringing therapies to patients. Founded in 2011, venBio manages venture funds with roughly $1.1 billion in committed capital and maintains offices in San Francisco and Seattle. The team focuses on helping portfolio companies position for strategic partnerships and potentialac